Chinese transnational adoptees worldwide were shocked, relieved, saddened, and frustrated all at once. Some had hoped to one ...

CB03-154 is a newer ALS therapy that's designed to open nerve cells' KCNQ2 and KCNQ3 potassium channels without affecting ...

After 25 years of global innovation, youth sports development, and IP creation, his company is now being recognized as one of ...